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Abstract The vasodilator-stimulated phosphoprotein (VASP)
functions as a cellular regulator of actin dynamics. VASP
may initialise actin polymerisation, suggesting a direct interac-
tion with monomeric actin. The present study demonstrates that
VASP directly binds to actin monomers and that complex for-
mation depends on a conserved four amino acid motif in the
EVH2 domain. Point mutations within this motif drastically
weaken VASP/G-actin interactions, thereby abolishing any ac-
tin-nucleating activity of VASP. Additionally, actin nucleation
was found to depend on VASP oligomerisation since VASP
monomers fail to induce the formation of actin ¢laments. Phos-
phorylation negatively a¡ects VASP/G-actin interactions pre-
venting VASP-induced actin ¢lament formation.
) 2002 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
The micro¢lament-associated vasodilator-stimulated phos-
phoprotein (VASP) is intimately involved in regulating actin
dynamics. VASP is not only prominent in adhesive structures
and stress ¢bres [1,2], but it also localises to the plasma mem-
brane in protruding lamellipodia [3,4] and ¢lopodial tips [5,6].
VASP belongs to the Ena/VASP proteins that are character-
ised by a tripartite domain structure (Fig. 1B): a central pro-
line-rich domain is £anked by two Ena/VASP homology do-
mains, EVH1 and EVH2. While the EVH1 domain targets
VASP to cell adhesion sites [7^9], the EVH2 domain binds
to and bundles actin ¢laments [10,11] and mediates VASP
oligomerisation [11]. The central proline-rich domain interacts
with pro¢lin [12] thereby possibly recruiting pro¢lin^actin
complexes [13^15].
Recent evidence shows that lamellipodial protrusion and
subcortical actin network organisation are regulated by Ena/
VASP proteins [4] with the actin binding EVH2 domain play-
ing a key role [16]. It has also been suggested that VASP may
directly stimulate actin ¢lament formation by direct binding
to G-actin and stabilisation of actin nuclei [10,14,17,18].
Many G-actin binding proteins share short basic sequence
motifs serving as the core of a recognition site for monomeric
actin and the EVH2 domain harbours such a KLRK motif
that is conserved among Ena/VASP family members (Fig. 1A).
We thus tested for a direct interaction of VASP with mono-
meric actin. Our data reveal that VASP-induced actin poly-
merisation depends on the formation of VASP/G-actin com-
plexes via the KLRK motif and is negatively a¡ected by
phosphorylation.
2. Materials and methods
2.1. Cloning of VASP constructs
Cloning of murine VASP was performed as described [10]. The
deletion construct comprising amino acids 1^342 (VASP-vC) was
generated by PCR using full-length VASP as a template. Ampli¢ca-
tion primers introduced EcoRI and XhoI restriction sites for further
cloning into the bacterial expression vector pQE30 (Qiagen, Hilden,
Germany). Site-directed mutagenesis was performed according to the
manufacturer’s instructions (Quick-change kit, Stratagene, Heidel-
berg, Germany) yielding VASP mutants with KLGE or KLEE instead
of the KLRK motif. All PCR-generated constructs were sequenced
prior to further cloning into bacterial expression vectors. Recombi-
nant proteins were equipped with additional sequence tags for immu-
nodetection: wild type VASP with the birch pro¢lin (BiPro)-tag [19],
the KLGE, KLEE and VASP-vC mutants with a FLAG-tag.
2.2. Protein expression, puri¢cation and analysis
Expression and puri¢cation of recombinant murine VASP con-
structs was as described [14]. Recombinant mouse pro¢lin I and IIa
were puri¢ed according to [20] with slight modi¢cations [14]. Rabbit
skeletal muscle actin was prepared as described [14,21].
2.3. Actin polymerisation assay
Actin polymerisation in the presence of VASP, pro¢lin I or IIa was
monitored by £uorimetry with 10% pyrene-labelled actin added to
unlabelled actin. Polymerisation assays with untreated actin were as
described [14]. 1 WM actin was pre-incubated in the absence or pres-
ence of 1 WM pro¢lin I or IIa, respectively, at 25‡C for 30 min in
G-actin bu¡er (25 mM HEPES, 0.2 mM CaCl2, 0.5 mM dithioery-
thritol, 1 mM ATP, pH 7.0). Polymerisation was initiated under F-ac-
tin conditions by adjusting the solution to 25 mM NaCl, 15 mM KCl,
2 mM MgCl2 and adding 0.25 WM VASP protein (wild type or mu-
tants). In polymerisation experiments with Escherichia coli protease-
treated (ECP)-actin (see below) 2 WM ECP-actin was pre-incubated in
G-actin bu¡er. 2 WM VASP, 25 mM NaCl, 15 mM KCl were added as
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described above in the presence of either 0.2 mM CaCl2 or 2 mM
MgCl2. Fluorescence was monitored for 60 min as described [14].
2.4. Preparation of ECP-actin
Proteolytically cleaved actin (ECP-actin) was prepared by incubat-
ing puri¢ed rabbit skeletal muscle actin (3 mg/ml) with partially pu-
ri¢ed E. coli A2 protease ECP32 at an enzyme to actin mass ratio of
1:100 for 2 h at room temperature as described previously [22]. Be-
cause ECP-actin is resistant to further degradation by this protease,
and the enzyme displays an extremely limited substrate speci¢city [23]
no protease inhibitor was added to stop the reaction. Cleaved actin
was lyophilised in the presence of 2 mM sucrose and stored in aliquots
at 380‡C.
2.5. VASP phosphorylation, chemical crosslinking and Western blot
analysis
Phosphorylation of wild type VASP by PKA was performed for
60 min as described [14]. All crosslinks were carried out in crosslink-
ing bu¡er (10 mM sodium phosphate bu¡er, pH 7.0; 20 mM NaCl;
50 mM KCl; 0.2 mM CaCl2 ; 0.2 mM ATP, 0.1 mM dithiothreitol
(DTT); 20 U/ml aprotinin) with 1 WM VASP proteins and/or 2 WM
ECP-actin (¢nal concentrations) in the absence of magnesium ions.
Samples were incubated at 30‡C for 25 min prior to chemical cross-
linking using ¢nal concentrations of 7 mg/ml N-hydroxysulfosuccin-
imide and 1.5 mg/ml 1-ethyl-3-[3-dimethylaminopropyl]carbodiimide
as described [2]. Reactions were terminated after 5 or 15 min by
addition of SDS sample bu¡er. Samples were analysed by SDS^
PAGE and subsequent Western blotting. Actin was detected using a
polyclonal anti-actin antibody (Sigma) while wild type BiPro-VASP
and FLAG-tagged VASP mutants were detected with a monoclonal
BiPro-tag antibody (4A6) [19] or the anti-FLAG antibody M2 (Sig-
ma), respectively.
2.6. Solid phase binding assay
The interaction between VASP and G-actin was monitored in an
ELISA essentially as described [14]. 50 pmol G-actin per well were
coated. Incubation with 0.1^100 pmol BiPro-tagged dephosphorylated
VASP or PKA-phosphorylated VASP was performed under physio-
logical conditions (phosphate-bu¡ered saline: 136 mM NaCl, 3 mM
KCl, 8 mM Na2HPO4, 1.5 mM KH2PO4, pH 7.2 with 0.05% Tween
20 and 0.5 mM DTT). Bound VASP was detected with the 4A6
BiPro-tag antibody as described [14].
3. Results
3.1. VASP mutants generated to analyse G-actin binding
VASP harbours a basic sequence motif within a highly con-
served region in the EVH2 domain that is reminiscent of the
core sequence of other G-actin binding proteins (Fig. 1A). In
thymosin L4, mutations of lysine residues in this motif signi¢-
cantly reduced its binding to G-actin [24]. Hence, VASP con-
structs were generated that yielded two VASP mutants,
KLGE and KLEE, respectively (Fig. 1B). In addition, we
also created a deletion construct (VASP-vC) lacking the
C-terminal oligomerisation domain [11]. All proteins were ex-
pressed as his-tag proteins in E. coli bearing additional se-
quence tags for immunodetection (see Section 2).
3.2. VASP-stimulated actin polymerisation requires an intact
KLRK motif and VASP oligomerisation
VASP-induced actin polymerisation can be monitored by
£uorescence spectroscopy using pyrenyl-labelled actin [10,
14]. When tested in this assay (Fig. 2A) only wild type
VASP induced actin polymerisation, whereas the curves for
both KLRK mutants and the VASP-vC construct were com-
parable to that of the actin control. This loss in actin poly-
merisation activity was not due to improper folding of the
mutants, since all proteins bound to F-actin in co-sedimenta-
tion assays (data not shown). Western blot analysis of all
VASP proteins subjected to chemical crosslinking in the ab-
sence of actin revealed that the VASP-vC construct remained
monomeric as predicted while the KLGE and KLEE mutants
were indistinguishable from the wild type. VASP dimers were
already prominent after 5 min of crosslinking, higher VASP
oligomers were observed after 15 min (Fig. 2B). These data
reveal that e⁄cient stimulation of actin polymerisation by
VASP depends on VASP oligomerisation as well as an intact
KLRK motif.
3.3. Direct binding of VASP to G-actin involves the KLRK
motif
Under physiological conditions, actin ¢lament formation
from G-actin is rapidly initiated and in the presence of re-
combinant murine VASP large aggregates of VASP and F-ac-
tin are formed. Hence, to test for direct binding of VASP to
monomeric actin, we used actin cleaved by ECP32 which
splits actin between glycine 42 and valine 43. The resulting
fragments remain in a non-convalent complex with the native
actin conformation [25]. ECP-actin does not polymerise under
calcium conditions and only to a very reduced level under
magnesium conditions [22,25]. These properties were con-
¢rmed in actin polymerisation assays (Fig. 3A and data not
shown). In the presence of 0.2 mM CaCl2, even the addition
of wild type VASP at equimolar concentrations did not pro-
mote the formation of actin ¢laments, while some polymeri-
sation was observed for Mg2þ-actin under similar conditions.
Subsequently, chemical crosslinks were performed in the ab-
sence of magnesium ions and analysed by Western blotting.
Fig. 1. VASP harbours a putative G-actin binding motif in the
EVH2 domain. A: Sequence comparison of recognised and sus-
pected G-actin binding motifs in several actin-associated proteins.
The KLKK motif crucial for G-actin binding in thymosin L4 [24]
also occurs in Ena/VASP proteins (black boxes). Homologous ami-
no acids are shaded. Asterisk indicates the in vivo phosphorylation
site S235 of murine VASP. B: Bar diagrams of murine VASP con-
structs used in this study. The EVH1 domains (black), the proline-
rich regions (white) and the EVH2 domains (grey) are indicated.
A=putative G-actin binding region; B=F-actin binding region;
C=oligomerisation domain.
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Probing for ECP-actin with an anti-actin antibody (Fig. 3B)
revealed that it remained as a monomer. With wild type
VASP, heterodimers with actin were already present after
5 min crosslinking (Fig. 3B, left panel) while complexes with
VASP-vC and both KLRK mutants were seen only after
15 min and in signi¢cantly smaller amounts as compared to
wild type VASP. The delayed heterodimer formation for
VASP-vC was somewhat surprising, since the KLRK motif
is intact in this protein, showing that deletion of the C-termi-
nal oligomerisation domain lowers the a⁄nity for binding
to monomeric actin which suggests an allosteric e¡ect on
the G-actin binding site. Except when VASP-vC was used,
ECP-actin was also present in aggregates of higher molecular
masses after 15 min, indicating that monomeric ECP-actin
may also associate with VASP oligomers (Fig. 3B, right pan-
el). The presence of VASP in hetero-oligomeric complexes was
con¢rmed by analysing the same samples for VASP proteins
after 5 min of chemical crosslinking (Fig. 3C). Heterodimer
formation was con¢rmed for the wild type as indicated by an
Fig. 2. VASP-stimulated actin polymerisation depends on both, an
intact KLRK motif and VASP oligomerisation. A: Fluorescence
spectroscopy with pyrenyl-labelled actin in the absence (3) or pres-
ence of recombinant his-tagged VASP wild type (1); VASP-vC (2);
VASP-KLGE (4) and VASP-KLEE (5). Final concentrations were
1 WM actin and 0.25 WM of the VASP constructs. B: Chemical
crosslink of VASP oligomers. Crosslinking reactions were termi-
nated after 5 min and 15 min, respectively. Lanes: 1=wild type
VASP; 2=VASP-vC; 3=VASP-KLGE; 4=VASP-KLEE.
 
Fig. 3. Direct binding of VASP to G-actin involves the KLRK mo-
tif. A: Polymerisation kinetics of ECP-actin (supplemented with
10% pyrenyl-labelled actin) in the absence (3) or presence (1, 2) of
equimolar amounts of wild type VASP. VASP-induced ECP-actin
polymerisation occurred in the presence of Mg2þ (1) but not Ca2þ
(2) ions. B: Western blot analysis of ECP-treated Ca2þ-actin (2 WM)
in the absence or presence of VASP proteins (1 WM) crosslinked for
5 or 15 min. ECP-actin controls (lane 1), VASP wild type (lane 2),
VASP-vC (lane 3) VASP-KLGE (lane 4), VASP-KLEE (lane 5). C:
Detection of VASP constructs after chemical crosslinking to EPC-
actin after 5 min. Lane 1P=VASP wild type; lane 2P=VASP-vC;
lane 3P=VASP-KLGE; lane 4P=VASP-KLEE. For interpretation
see text.
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additional band below the VASP homodimer. In addition,
faint signals indicative of heterodimers that had not been
observed when probing for ECP-actin were also detectable
for VASP-vC, KLGE and KLEE (Fig. 3, compare B with
C). This discrepancy may re£ect di¡erent a⁄nities of the anti-
bodies. After 15 min of crosslinking, VASP/actin complexes of
higher molecular masses were also detected. However these
complexes could not be well resolved, since the presence of
VASP oligomers in addition to VASP^actin hetero-oligomers
resulted in a broad smear in the upper part of the Western
blot (data not shown). The binding of VASP to immobilised
ECP-actin under physiological conditions was also tested in a
solid phase binding assay (data not shown) comparable to the
assay depicted in Fig. 5 for VASP and G-actin. Taken togeth-
er, these experiments demonstrate that VASP directly binds to
G-actin with the KLRK motif being involved in this interac-
tion.
3.4. Recruitment of pro¢lin^actin complexes does not rescue
the actin polymerisation de¢ciencies of mutant VASP
proteins
VASP may recruit pro¢lin^actin complexes [12,13,15]. To
test if this recruitment was su⁄cient for ¢lament formation
independently of the KLRK motif, we analysed VASP-in-
duced actin polymerisation from pre-formed actin^pro¢lin
complexes (Fig. 4). Actin nucleation and polymerisation by
wild type VASP were enhanced in the presence of pro¢lin I
and pro¢lin IIa. In the absence of VASP, there was a slight
sequestering e¡ect (cf. [14]) due to the formation of pro¢lin^
actin heterodimers resulting in a net decrease of free actin
monomers (Fig. 4A). The addition of neither VASP-vC
(Fig. 4B) nor the KLRK mutants (Fig. 4C, and data not
shown) to pro¢lin I^actin solutions resulted in actin ¢lament
formation, again arguing for oligomerisation and a functional
KLRK motif being instrumental for actin polymerisation by
VASP.
3.5. Binding of VASP to monomeric actin is regulated by
phosphorylation
As VASP phosphorylation reduces its interaction with
F-actin [14] chemical crosslinks were performed with non-
polymerisable ECP-actin and VASP that had been phosphor-
ylated by PKA for 60 min (Fig. 5A). Under the conditions
used, the physiological phosphorylation site S235 that neigh-
bours the KLRK motif (Fig. 1A) is phosphorylated to almost
stoichiometric levels and VASP stimulation of actin polymer-
isation is abolished [14]. Western blots probing for ECP-actin
(Fig. 5A, left two panels) and VASP (Fig. 5A, right panel)
showed that after 5 min of crosslinking, heterodimers were
only observed for non-phosphorylated VASP (Fig. 5A, left
panel). Heterodimer formation was notable for phosphorylat-
ed VASP after 15 min, but to a lesser extent than for the wild
type (Fig. 5A, middle panel). Probing for VASP proteins
(Fig. 5A, right panel) revealed no di¡erence in dimerisation
between both VASP populations. The decrease in heterodimer
formation was due to a reduced binding to G-actin as seen in
a solid phase binding assay (Fig. 5B). Immobilised G-actin
was incubated with increasing amounts of VASP or phos-
pho-VASP under physiological conditions. The G-actin con-
formation was demonstrated by analysing the binding of pro-
¢lin I to immobilised G-actin (data not shown). While
dephosphorylated VASP bound to G-actin was readily detect-
Fig. 4. Pro¢lin^actin complexes do not substitute for defective G-ac-
tin binding by the mutant VASP proteins. A^C: Kinetics of actin
¢lament formation from pro¢lin^actin in the absence or presence of
VASP proteins. Equimolar amounts of actin and pro¢lin I/pro¢lin
IIa (1 WM) were incubated prior to the addition of any VASP con-
struct to allow pro¢lin^actin complex formation. 0.25 WM VASP
wild type (A), VASP-vC (B) or VASP-KLGE (C) were then added
to the samples and actin polymerisation was monitored by £uores-
cence spectroscopy. A: Induction of actin polymerisation by wild
type VASP (3) is enhanced in the presence of either pro¢lin IIa (1)
or pro¢lin I (2) while in the absence of VASP both pro¢lins sup-
press actin ¢lament formation (5,6) below the actin control (4), due
to a slight sequestering e¡ect. B: VASP-vC cannot substitute for
wild type VASP. (1) Actin control; (2) actin and pro¢lin I; (3) actin
and VASP-vC; (4) actin, VASP-vC and pro¢lin I. C: The KLGE
mutant fails to promote pro¢lin^actin-based actin polymerisation.
(1) Actin control; (2) actin and pro¢lin I; (3) actin, VASP-KLGE
and pro¢lin I; (4) actin and VASP-KLGE.
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able at 0.5 pmol protein per well and increased with higher
amounts of VASP protein (Fig. 5B, grey bars), phospho-
VASP was detected as a ligand for G-actin only above
5 pmol VASP per well, con¢rming that binding of VASP to
G-actin is weakened and can thus be regulated by phosphor-
ylation.
4. Discussion
Based on recent ¢ndings that VASP may initiate actin poly-
merisation, we hypothesised that VASP directly interacted
with actin monomers and that a basic four amino acid motif
(KLRK) located within the ¢rst conserved sequence block of
the EVH2 domain [11] was the core sequence of a G-actin
binding motif. We also postulated that the formation of a
single VASP/actin heterodimer would not su⁄ce for actin
nuclei formation, but that oligomerisation was necessary to
induce actin polymerisation. We demonstrate that VASP and
G-actin interact physically and that the KLRK motif is indeed
involved in complex formation. Mutations of the arginine/ly-
sine tandem residues signi¢cantly reduced VASP binding to
G-actin and prevented de novo formation of actin ¢laments in
vitro. Furthermore, the latter also requires VASP oligomerisa-
tion, probably allowing recruitment of multiple actin mono-
mers.
The generation of the KLRK mutants was based on a de-
tailed analysis of the G-actin binding site in thymosin L4 by
mutational analyses [24]. This study revealed that while the
replacement of any lysine residue within the KLKK motif
(Fig. 1A) signi¢cantly weakened thymosin L4/G-actin interac-
tions, a complete loss of G-actin binding was only achieved by
introducing negative charges, replacing the lysines for gluta-
mic acid residues. In analogy to these ¢ndings, we generated
the KLGE and KLEE mutants that are both de¢cient in
G-actin binding (Fig. 3) and failed to promote actin polymer-
isation (Figs. 2 and 4). Interestingly, the physiological phos-
phorylation site S235/S239 of murine and human VASP, re-
spectively [14,26] (asterisk in Fig. 1A) lies next to the KLRK
motif. Phosphorylation of this residue abolishes VASP-in-
duced actin polymerisation [14] and phosphorylation of the
equivalent site in Mena has recently been shown to be crucial
for its physiological function [16]. The similarity of the results
obtained in our study with the KLRK mutants and with wild
type VASP phosphorylated by c-AMP-dependent kinase
(compare Figs. 3 and 5) indicates that binding of VASP to
G-actin signi¢cantly depends on electrostatic interactions that
are negatively in£uenced by phosphorylation.
Our data also revealed that the direct interaction of VASP
with monomeric actin is crucial for stimulation of actin ¢la-
ment formation, since the addition of pro¢lin^actin complexes
that should bind to the GP5 motifs in VASP [12,13] and
deliver actin monomers could not rescue the function of the
mutant proteins. There is also good evidence for the physio-
logical relevance of VASP/G-actin interactions: recent analy-
ses of Mena/VASP-de¢cient MVD7 cells revealed that the or-
ganisation of the subcortical actin ¢laments and lamellipodial
protrusion may be regulated by Ena/VASP proteins [4]. In
addition, deletion constructs of Mena lacking the KLRK con-
taining region failed to induce the motility phenotype of cells
re-expressing wild type Mena [16] arguing for a signi¢cant
contribution of this motif for Ena/VASP-induced actin poly-
merisation in vivo.
It is noteworthy that many of the nucleating proteins (e.g.
the WASP/Scar and formin proteins; cf. [27^29]) harbour
their own G-actin binding sites, in addition to binding to
pro¢lin^G-actin. Possibly, the G-actin monomers, once re-
leased from pro¢lin^actin complexes, need to be tethered to
the nucleator proteins like VASP for e⁄cient concentration or
orientation during the relatively slow process of nucleus for-
mation. It is also conceivable that this interaction might
change the conformation of actin as present in the pro¢lin^
actin complex, to a slightly di¡erent structure favourable for
actin nucleation and elongation (cf. [30,31]).
In conclusion, we propose that the physical interaction of
VASP with G-actin is essential for the physiological function
Fig. 5. Phosphorylation of VASP signi¢cantly diminishes binding of
VASP to monomeric actin. A: Chemical crosslinking of ECP-actin
and VASP before and after phosphorylation (60 min) by PKA.
Western blot analyses of actin after 5 and 15 min of crosslinking
(left two panels) and (right panel). 1 =Actin control; 2 =PKA-phos-
phorylated VASP+actin; 3 = non-phosphorylated VASP+actin. See
text for analysis. B: Solid phase binding assay (ELISA) of G-actin
and VASP. G-actin (50 pmol) was coated onto ELISA-plates and
incubated with increasing amounts of non-phosphorylated (grey
bars) and phosphorylated VASP protein (black bars) under physio-
logical conditions (phosphate-bu¡ered saline). Controls: ^A=no ac-
tin coated; ^V=no VASP protein added; ^Ab=no primary anti-
body.
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of VASP and can be regulated by phosphorylation. Further-
more, our data favour the concept that the conformation of
monomeric actin may be modulated by binding to di¡erent
ligands such as pro¢lin or VASP.
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